Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Indometacin
Sandoz Ltd
M01AB01
Indometacin
50mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010100
296x210 Leaflet Reel Fed Bi Fold Profile (BST) Dimensions: Component: Date Sent: Technologist: TECHNICALLY APPROVED Pharmacode: JDE No.: Indometacin Hard Capsules 25, 50mg x 28’s (UK) 296x210 (Reel Fed) 50967738 Leaflet for Blisters 4453 T. Hull 01/05/19 * Please note that ONLY Artwork Studio is permitted to make changes to the above artwork. No changes are permitted by any 3rd party other than added notes and mark ups for required changes. approved for print/date PROOF ROUND UK-Eire-Artwork-Support@accord-healthcare.com Technical Approval NON PRINTING COLOURS COLOURS DATE SENT: DATE RECEIVED: Item number: ORIGINATOR: ORIGINATION DATE: REVISION DATE: REVISED BY: DIMENSIONS: MIN BODY TEXT SIZE: SUPPLIER: 1. 2. 3. 4. 5. 6. 1. 2. 3. FMD info NA (not a carton) No Yes Details INDOMETACINE 25MG & 50MG 28 TABS PIL - UK Black Profile BBBA4736 RH 09-05-19 11-11-19 RH 296x210 10pt Accord Barnstaple NA NA 05 Version 2 01.11.2017 page 4 page 1 50967738 BBBA4736 page 4 page 1 INDOMETACIN 25MG AND 50MG CAPSULES READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1 WHAT INDOMETACIN CAPSULES ARE AND WHAT THEY ARE USED FOR 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE INDOMETACIN CAPSULES 3 HOW TO TAKE INDOMETACIN CAPSULES 4 POSSIBLE SIDE EFFECTS 5 HOW TO STORE INDOMETACIN CAPSULES 6 CONTENTS OF THE PACK AND OTHER INFORMATION 1 WHAT INDOMETACIN CAPSULES ARE AND WHAT THEY ARE USED FOR Indometacin capsules belong to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). These medicines ar Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Indometacin Capsules BP 50mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Indometacin BP 50mg 3 PHARMACEUTICAL FORM Capsules 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Indometacin is a non-steroidal anti-inflammatory agent indicated for the active stages of :-Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis, Acute Musculoskeletal Disorders, Degenerative Joint Disease of the Hip, Low Back Pain and Acute Gout. It is also indicated for Pain, Inflammation and Oedema following Orthopaedic procedures and pain associated symptoms of primary Dysmenorrhoea. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). ADULTS: The recommended oral dosage range is 50- 200mg daily in divided doses. Dysmennorrhoea: Up to 75mg daily, staring with onset of symptoms and continuing for as long as they usually last. Acute Gouty Arthritis: 150 - 200mg daily in divided doses until all signs and symptoms subside. CHILDREN: Safety and dosage has not been established, but Indometacin has been shown to be effective in Juvenile Rheumatoid Arthritis with a dosage range of 1.5- 3mg/kg/day and a maximum daily dosage of 200mg. ELDERLY: Indometacin should be used with great care in elderly patients who are more prone to side effects. RENAL IMPAIRMENT/HEPATIC DISEASE: The use of Non-Steroidal anti-inflammatory Agents may result in deterioration of renal function. Renal function should be monitored (see warnings/precautions) 4.3 CONTRAINDICATIONS Hypersensitivity to Indometacin or to any of the exipients listed in section 6.1. NSAIDs are contraindicated in patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to ibuprofen, aspirin or other non-steroidal anti-inflammatory drugs. Nasal polyps associated with angioneurotic oedema. Severe hepatic, renal and cardiac failure Read the complete document